Zhejiang Shengda Bio-Pharm Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 390.135 million compared to CNY 450.438 million a year ago. Operating income was CNY 49.987 million compared to CNY 177.916 million a year ago. Net income was CNY 47.889 million compared to CNY 151.428 million a year ago. Basic earnings per share from continuing operations was CNY 0.28 compared to CNY 0.9 a year ago. Diluted earnings per share from continuing operations was CNY 0.28 compared to CNY 0.86 a year ago.